🧪 Taking a daily oral semaglutide reduced major adverse cardiovascular events by 14% in people with type 2 diabetes and CVD risk factors compared to taking a placebo, a trial in JAMA Cardiology found. Benefits to A1c, body weight, and blood & pulse pressure lasted >3 years: https://ow.ly/iKVz50Z8T4f
